Lyon. Bioterrorism: Fabentech Enters the Court of Greats with the World's First Antidote Against Ricin
5 Articles
5 Articles
Sixteen years after its creation, Fabentech has just obtained its first marketing authorisation for an antidote against ricin poisoning. This treatment, the Ricimed, is a world first in an international niche market. It allows Lyon biotech to position itself as "the European leader in the fight against biological threats", says Sébastien Iva, President of the Executive Board.
A Lyon company will market an antidote against the effects of ricin. This natural substance is a deadly poison considered a bioterrorist risk.
The government has announced the placing on the market of an antidote against ricin, developed by a French SME specializing in the fight against biological threats. "Ensuring the protection of citizens from major biological risks is a public health priority," said Minister of Health Stéphanie Rist.
The government has announced the commercialization of Ricimed®, the world's first antidote against ricin. Developed by the Lyon SME, with the support of the Ministries of Health and Armed Forces, this treatment aims to fill a therapeutic vacuum in the face of a toxin feared for its potential...
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

